IDEXX Laboratories Statistics
NASDAQ: IDXXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
519.54+6.40 (+1.25%)
Market open · Delayed 15 min · as of Oct 9, 12:15 PM ET
IDEXX Laboratories by the numbers
IDEXX Laboratories has a market capitalization of $40.93 billion based on 78.78M shares outstanding. Its trailing P/E ratio is 36.5, and its forward P/E is 31.0. The stock trades 3.8% below its 50-day average and 11.1% below its 200-day average.
Average daily trading volume is 553.95K shares, or about $287.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IDXX valuation vs. peer median
| Metric | IDXX | Peer median | Difference |
|---|---|---|---|
| Market cap | $40.93B | $2.08B | +1869% |
| Forward P/E | 31.0 | 15.7 | +97% |
| Avg. volume | 553.95K | 1.38M | -60% |
Peer median across 8 companies: LNTH, ORKA, NEOG, CLDX, NTLA, QDEL, ACHV, TKNO.
Valuation
- Market cap
- $40.93B
- P/E (TTM)
- 36.51
- Forward P/E
- 31.04
- Price / sales (latest FY)
- 9.51
- EPS (TTM)
- $14.23
- Shares outstanding
- 78.78M
Price and trading
- Previous close
- 513.14
- Open
- 513.67
- Day range
- 513.15 – 521.99
- 52-week range
- 500.61 – 769.98
- 52-week change
- -18.54%
- 50-day moving average
- 540.25
- 200-day moving average
- 584.33
- Beta
- —
- Volume
- 107.07K
- Average volume
- 553.95K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 40.93B
- Pe
- 36.51
- Forward Pe
- 31.04
- Eps
- 14.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 769.98
- Week52 Low
- 500.61
- Avg Volume
- 553.95K
- Shares Outstanding
- 78.78M
- Ma50
- 540.25
- Ma200
- 584.33
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -32.53%
- Pct From52w Low
- 3.78%